Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: Special references to lymphomas surrounding this newly recognized clinicopathologic disease

Cancer Science

Volumn 99, Issue 6, 2008, Pages 1085-1091

  Shimoyama, Yoshie ^a   Yamamoto, Kazuhito ^b,e   Asano, Naoko ^c   Oyama, Takashi ^d   Kinoshita, Tomohiro ^e   Nakamura, Shigeo ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c SHINSHU UNIVERSITY HOSPITAL   (Japan)

^d NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^e NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGE RELATED EPSTEIN BARR VIRUS ASSOCIATED B CELL LYMPHOPROLIFERATIVE DISORDER; AGING; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER MORPHOLOGY; CLASSICAL HODGKIN LYMPHOMA; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPSTEIN BARR VIRUS; GENERAL CONDITION DETERIORATION; GENOTYPE; GIANT CELL; HEALTH STATUS; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; IMMUNOBLAST; IMMUNOPHENOTYPING; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; VIRUS CARCINOGENESIS;

AGED; AGING; B-LYMPHOCYTES; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; LYMPHOPROLIFERATIVE DISORDERS;

EID: 43549113655     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00813.x     Document Type: Review

References (37)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haemotopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001.
2. Lymphoma Study Group of Japanese Pathologist. The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities. Pathol Int 2000; 50: 696-702.
3. Gandhi MK, Tellam JT, Khanna R. Epstein-Barr virus-associated Hodgkin's lymphoma. Br J Haematol 2004; 125: 267-81.
4. Park S, Lee J, Ko YH et al. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 2007; 110: 972-8.
5. Oyama T, Ichimura K, Suzuki R et al. Senile EBV + B-cell lymphoproliferative disorders: A clinicopathologic study of 22 patients. Am J Surg Pathol 2003; 27: 16-26.
6. Shimoyama Y, Oyama T, Asano N et.al. Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: A mini review. J Clin Exp Hematop 2006; 46: 1-4.
7. Oyama T, Yamamoto K, Asano N et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: A study of 96 patients. Clin Cancer Res 2007; 13: 5124-32.
8. Kuze T, Nakamura N, Hashimoto Y, Sasaki Y, Abe M. The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV + and EBV -cases in Japanese population. Jpn J Cancer Res 2000; 91: 1233-40.
9. Yoshino T, Nakamura S, Matsuno Y et al. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma. Cancer Sci 2006; 97: 163-6.
10. Kojima M, Kashimura M, Itoh H et al. Epstein-Barr virus-related reactive lymphoproliferative disorders in middle-aged or elderly patients presenting with atypical features. A clinicopathological study of six cases. Pathol Res Pract 2007; 203: 587-91.
11. Weiss LM, Chen YY, Liu XF, Shibata D. Epstein-Barr virus and Hodgkin's disease. A correlative in.situ hybridization and polymerase chain reaction study. Am J Pathol 1991; 139: 1259-65.
12. Pileri SA, Ascani S, Leoncini L et al. Hodgkin's lymphoma: The pathologist's viewpoint. J Clin Pathol 2002; 55: 162-76.
13. Amini RM, Enblad G. Relationship between Hodgkin's and non-Hodgkin's lymphomas. Med Oncol 2003; 20: 211-20.
14. Yung L, Linch D. Hodgkin's lymphoma. Lancet 2003; 361: 943-51.
15. Asano N, Oshiro A, Matsuo K et al. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: A clinicopathologic study. J Clin Oncol 2006; 24: 4626-33.
16. Jarrett RF, Krajewski AS, Angus B et al. The Scotland and Newcastle epidemiological study of Hodgkin's disease: Impact of histopathological review and EBV status on incidence estimates. J Clin Pathol 2003; 56: 811-16.
17. Jarrett RF, Stark GL, White J et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: A population-based study. Blood 2005; 106: 2444-51.
18. Armstrong AA, Alexander FE, Cartwright R et al. Epstein-Barr virus and Hodgkin's disease: Further evidence for the three disease hypothesis. Leukemia 1998; 12: 1272-6.
19. Poppema S, Visser L. Epstein-Barr virus positivity in Hodgkin's disease does not correlate with an HLA A2-negative phenotype. Cancer 1994; 73: 3059-63.
20. Clarke CA, Glaser SL, Dorfman RF et al. Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women. Cancer 2001; 91: 1579-87.
21. Glaser SL, Lin RJ, Stewart SL et al. Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data. Int J Cancer 1997; 70: 375-82.
22. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991; 337: 320-2.
23. Herbst H, Steinbrecher E, Niedobitek G et al. Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood 1992; 80: 484-91.
24. Flavell KJ, Biddulph JP, Constandinou CM et al. Variation in the frequency of Epstein-Barr virus-associated Hodgkin's disease with age. Leukemia 2000; 14: 748-53.
25. Glaser SL, Dorfman RF, Clarke CA. Expert review of the diagnosis and histologic classification of Hodgkin disease in a population-based cancer registry: Interobserver reliability and impact on incidence and survival rates. Cancer 2001; 92: 218-24.
26. Stark GL, Wood KM, Jack F et al. Hodgkin's disease in the elderly: A population-based study. Br J Haematol 2002; 119: 432-40.
27. Enblad G, Sandvej K, Sundstrom C, Pallesen G, Glimelius B. Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population. Acta Oncol 1999; 38: 425-9.
28. Glavina-Durdov M, Jakic-Razumovic J, Capkun V, Murray P. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease. Br J Cancer 2001; 84: 1227-34.
29. Flavell KJ, Billingham LJ, Biddulph JP et al. The effect of Epstein-Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's disease. Ann Oncol 2003; 14: 282-90.
30. Küppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med 1999; 341: 1520-9.
31. Küppers R. B cells under influence. transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 2003; 3: 801-12.
32. Marafioti T, Hummel M, Foss HD et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95: 1443-50.
33. Kanzler H, Kuppers R, Hansmann ML, Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996; 184: 1495-505.
34. Timms JM, Bell A, Flavell JR et al. Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: Similarities to EBV-positive Hodgkin's lymphoma. Lancet 2003; 361: 217-23.
35. Yasunaga J, Sakai T, Nosaka K et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood 2001; 97: 3177-83.
36. Harada S, Kamata Y, Ishii Y et al. Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection. Clin Diagn Laboratory Immunol 2004; 11: 123-30.
37. Rudiger T, Jaffe ES, Delsol G et al. Workshop report on Hodgkin's disease and related diseases ('grey zone'lymphoma). Ann Oncol 1998; 9 (Suppl. 5): S31-8.